Key result
Arachidonic acid pretreatment significantly reduced aspirin-induced microvascular damage and deep mucosal necrosis in rats, which otherwise caused a three-fold reduction in vimentin fluorescence.
Why the study?
Does arachidonic acid pretreatment prevent aspirin-induced gastric mucosal microvascular injury in rats?
Does arachidonic acid pretreatment prevent aspirin-induced gastric mucosal microvascular injury in rats?
Arachidonic acid pretreatment protects against aspirin-induced gastric mucosal microvascular injury in a rat model.
Microvessel injury in aspirin gastropathy merits human investigation; animal findings leave open arachidonic acid gastroprotection for clinical testing.
Exposure of the gastric mucosa to aspirin results in exfoliation of the surface epithelium and deep mucosal necrosis. We assessed the changes in the mucosal microvessels during aspirin-induced injury and arachidonic acid protection of the gastric mucosa using transmission electron microscopy. Male Sprague-Dawley rats received intragastric pretreatment with either solubilizer (control) or detergent solubilized arachidonic acid (148 mg kg-1). One hour later 1-ml suspension of 200 mg kg-1 body weight acidified aspirin was administered intragastrically. The ultrastructure of mucosal microvasculature was assessed at 15 min and 4 h after aspirin administration both qualitatively and quantitatively by determining the number of necrotic or damaged capillaries in standardized mucosal sections. In addition, mucosal specimens were immunostained with a specific antiserum against vimentin, an endothelial marker, and fluorescence intensity was measured with a Nikon FX microscopic photometric system. In control rats, aspirin produced significant damage to both superficial and deeper microvessels consisting of: rupture of capillary walls, necrosis of endothelial cells, damage to endothelial organelles, deposition of fibrin and adherence of platelets to damaged endothelium. Vimentin fluorescence was reduced three-fold. Microvascular injury preceded the development of deep necrotic lesions. Microvascular damage and deep mucosal necrosis were significantly reduced by arachidonic acid pretreatment. We conclude that gastric mucosal microvessels are the major target for aspirin-induced injury and arachidonic acid protection.
No takes yet. Share an insight, caveat, or question.
Tarnawski et al. (1990) studied Aspirin-induced gastric mucosal injury. Arachidonic acid vs. Solubilizer (control) was evaluated on Number of necrotic or damaged capillaries and vimentin fluorescence intensity. Arachidonic acid pretreatment significantly reduced aspirin-induced microvascular damage and deep mucosal necrosis in rats, which otherwise caused a three-fold reduction in vimentin fluorescence.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: